BIOT

Biotech Acquisition Company Class A Ordinary Shares
BIOT

Delisted

BIOT was delisted on the 2nd of February, 2023.

Back to rankings

51 hedge funds and large institutions have $121M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$86K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.57M
2
+$5.7M
3
+$4.98M
4
DCM
DG Capital Management
New York
+$4.35M
5
RCM
Radcliffe Capital Management
Pennsylvania
+$3.92M

Top Sellers

1
-$2.92M
2
-$1.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.45M
27
$1.4M
28
$1.39M
29
$1.39M
30
$1.28M
31
$1.21M
32
$1.2M
33
$967K
34
$967K
35
$967K
36
$966K
37
$941K
38
$859K
39
$585K
40
$559K
41
$484K
42
$484K
43
$475K
44
$359K
45
$242K
46
$242K
47
$230K
48
$103K
49
$98K
50
$5.8K
1
2
3